Publication | Open Access
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
19
Citations
35
References
2012
Year
Hematological MalignancyMedicineMalignant Blood DisorderHematologyPharmacologyPathologyPharmacotherapyBcr-abl+ Hematological MalignanciesOncologyImatinib MesylateCancer ResearchMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1